Announcements
- IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
- IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
- IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
- IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
- IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
- IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
- IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
- IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
- IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
- IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
More ▼
Key statistics
On Thursday, IRadimed Corp (46K:FRA) closed at 37.40, 7.47% above its 52-week low of 34.80, set on Oct 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 37.40 |
---|---|
High | 37.40 |
Low | 37.40 |
Bid | -- |
Offer | -- |
Previous close | 37.40 |
Average volume | 0.00 |
---|---|
Shares outstanding | 12.66m |
Free float | 7.97m |
P/E (TTM) | 29.96 |
Market cap | 512.46m USD |
EPS (TTM) | 1.35 USD |
Annual div (ADY) | 0.545 EUR |
---|---|
Annual div yield (ADY) | 1.46% |
Div ex-date | Dec 21 2023 |
Div pay-date | Jan 12 2024 |
Data delayed at least 15 minutes, as of Apr 18 2024 07:01 BST.
More ▼